Environment, genetics may increase incidence of Parkinson's
Q. Is it true that pesticides are responsible for people getting Parkinson's disease?
Although genetics is very important in Parkinson's disease, environmental exposures also increase a person's risk of developing the disease. Scientists have known for some time that farm workers who used pesticides, or people who lived or worked near fields where they could inhale drifting pesticides, have an increased risk of the disease.
Parkinson's disease was first described in 1817 by Dr. James Parkinson, a British physician. It affects 1 in 100 people over the age of 60. It can also affect younger people. The average age of onset is 60. Research suggests that it affects at least 500,000 people in the United States.
Parkinson's disease is a complex disorder of the central nervous system. It is the second most common neurodegenerative disease in the United States, after Alzheimer's.
The defining symptoms of Parkinson's disease include tremor, slowness of movement, rigidity, and impaired balance and coordination. As these symptoms become more pronounced, patients may have difficulty walking, talking or completing simple tasks. They also may experience depression, difficulty sleeping and other problems.
The progression of symptoms may take 20 years or more. In some people, however, the disease progresses much more quickly.
In the early 1960s, scientists determined that the loss of brain cells was causing Parkinson's disease. The cells that were depleted produced dopamine, a chemical that helps control muscle activity. Today, the disease is treated with drugs and surgery.
Medications for Parkinson's disease fall into three categories. The first includes drugs that increase the level of dopamine in the brain. The second category affects neurotransmitters in the body to ease some of the symptoms of the disease. The third category includes medications that help control the non-motor symptoms of the disease such as depression.
There are two commonly used surgical treatments for Parkinson's disease: pallidotomy and deep brain stimulation. Because these procedures are invasive, they are usually reserved for severely afflicted Parkinson's patients who do not get adequate relief from medications.
Surgeons discovered that, by removing or destroying parts of the brain that were "misfiring," some of the symptoms of the disease could be alleviated. One of these operations is pallidotomy.
Scientists have found that they can mimic the effects of pallidotomy by deep brain stimulation. With DBS, an electrode is implanted in the brain in a way that calms the abnormal neuronal firing. DBS is now the primary surgical intervention for Parkinson's disease.
A wide variety of complementary and supportive therapies may be used for Parkinson's disease. Among these therapies are standard rehabilitation techniques, which can help with problems such as gait and voice disorders, tremors and rigidity, and cognitive decline. Exercise may help people improve their mobility.
While Parkinson's is a complex disease, research has progressed a great deal in recent years. Halting the progression of the disease, restoring lost function, and even preventing the disease are now considered realistic goals.
If you would like to ask a question, write to firstname.lastname@example.org.
The Times News, Inc., and affiliates (TIMES NEWS) do not endorse or recommend any medical products, processes, or services or provide medical advice. The views of the author do not necessarily state or reflect those of the TIMES NEWS. The article content is not intended as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, or other qualified health provider with any questions you may have regarding a medical condition.